Smith & Nephew plc ADR Stock
Price
Target price
€23.20
€23.20
-
-
-
-
09.05.24 / Frankfurt
WKN: 939163 / Symbol: SNN / Name: Smith & Nephew / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | - | 3.571% | 3.571% | -18.881% | -5.691% | -35.556% | -36.957% |
| Smith & Nephew plc | 1.410% | 1.825% | 1.780% | -19.200% | -6.165% | -35.445% | - |
| Dentsply Sirona Inc. | -0.460% | -1.664% | -14.106% | -30.370% | -19.204% | -53.786% | -46.792% |
| Dexcom Inc. | -1.750% | 1.525% | -7.374% | 9.784% | 7.038% | 62.605% | 360.215% |
Comments
Smith & Nephew plc (NYSE: SNN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for SNN provided by MarketBeat
